Mycobacterial cellular components

Mycobacterial cellular components refer to the diverse structural and functional elements of bacteria within the genus Mycobacterium, most notably Mycobacterium tuberculosis. These components include a unique, lipid-rich cell wall composed of mycolic acids, arabinogalactan, and peptidoglycan, as well as essential intracellular machinery such as the 30S and 50S ribosomal subunits, DNA gyrase, and RNA polymerase. The complex architecture of the mycobacterial cell wall provides a formidable permeability barrier, contributing to the intrinsic resistance of these organisms to many standard antibiotics. In the context of pharmacology, these components serve as the primary targets for anti-tubercular and anti-leprotic drugs. For instance, Isoniazid targets the synthesis of mycolic acids, while Rifampin inhibits the bacterial RNA polymerase to prevent transcription. Because 'Mycobacterial cellular components' is a collective term rather than a single molecular entity, it encompasses multiple distinct therapeutic targets that are critical for the survival, replication, and pathogenesis of mycobacteria. Targeting these components is the cornerstone of treating chronic infections like tuberculosis, though the emergence of drug-resistant strains remains a significant global health challenge.

Other names

Mycobacterial cell wallMycobacterial ribosomeMycobacterial DNA gyraseMycobacterial RNA polymeraseMycobacterial metabolic enzymes

Inhibition of mycolic acid synthesis (Isoniazid), inhibition of DNA-dependent RNA polymerase (Rifampin), inhibition of arabinosyltransferase (Ethambutol), inhibition of ATP synthase (Bedaquiline), and inhibition of protein synthesis (Streptomycin/Linezolid).